Search

Background: The outbreak of COVID-19 infection in humans first reported in Wuhan (China) which has spread around the world and having a significant impact on global health and mental health. It has caused widespread psychosocial and behavioural changes as a result of mass hysteria, economic burden, and financial losses, in addition to its high infectivity and the increased mortality rates. Method: Published articles regarding to mental health related to the COVID-19 outbreak and other previous global infections have been considered and reviewed. Comments: The pervasive fear of COVID-19, named as "coronaphobia," has resulted with a slew of psychiatric manifestations in people from all walks of life. It has affected people from all the point of life, resulting in a variety of psychiatric issues such as anxiety, post-traumatic stress disorder (PTSD), fear and uncertainty, panic attacks, depression, obsessive compulsive disorder, xenophobia, and racism. Collective concerns have an impact on daily behaviours, the economy, prevention strategies, and decision-making by policymakers, health organisations, and medical centres, which can weaken COVID-19 control strategies and lead to increased morbidity and mental health needs on a global level.

Misuse, violence, and distribution of opioids are also a public health concern. Pharmacists are at the forefront of the health-care response to the opioid epidemic because they have more opportunities to engage with patients than primary care or specialist medical practitioners. Because of these situations, pharmacists have more chances to provide proper prevention advice and reinforce proper opioid drug usage. Understanding dosage restrictions, learning how to use prescription drug monitoring programmes, knowing when drug take-back programmes are taking place, and advising consumers about the dangers of substance addiction are both techniques that pharmacists should be informed about. Recognising "red flag" actions that may suggest opioid abuse; using tests to determine a patient's risk of opioid abuse; collaborating with other health-care providers to plan a patient's treatment; knowing how abuse-deterrent antidepressants function and what they can't do. Pharmacists can help mitigate substance misuse and improve patient outcomes by implementing these techniques. All patients who require legitimate and effective pain management through the use of opioids must have access to them. While further study is needed in a variety of areas, pharmacists may make efforts today to follow proposed recommendations, rules, and legislation to reduce drug misuse and diversion of restricted drugs.